ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
AH
Accord Healthcare at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Accord Healthcare takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 1018. Its program centres on choosing immunotherapy as a first-line treatment in lung cancer. It covers both extensive-stage small cell lung cancer and non-small cell lung cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
AH Accord Healthcare | |
Generic and biosimilar medicines company, part of India's Intas Pharmaceuticals, with a large oncology portfolio. | Booth Exhibiting at Booth 1018 Satellite Mon Oct 26 18:30–20:00 Accord Healthcare - Navigating immunotherapy options in first-line ES-SCLC and NSCLC Lung & thoracic cancers |
Find decision makers at Accord Healthcare
Tell us what you sell and we’ll find the people at Accord Healthcare most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction